A Randomized, Double-Blind, Placebo-Controlled Study Of Lasmiditan For Acute Treatment Of Migraine In Children Aged 6 to 17

TITLE:

MEDICAL CONTION:

Pediatric Migraine

AGE:

SEX/GENDER:

Overview

Study Details